LEADER 00892nam a2200241 i 4500
001 991000269939707536
008 090603s1997    it            000 0 ita d
020   $a8872846439
035   $ab13834125-39ule_inst
040   $aDip.to Filosofia$bita
082 0 $a330
100 1 $aFantozzi, Pietro$0133987
245 10$aComunitá, societá e politica nel Sud d'Italia /$cPietro Fantozzi.
260   $aSoveria Mannelli :$bRubbettino,$c1997
300   $a141 p. ;$c21 cm
440  0$aUniversitá
651  0$aItalia meridionale$xCondizione sociale$y1945-
907   $a.b13834125$b02-04-14$c03-06-09
912   $a991000269939707536
945   $aLE005 330 FAN02. 01$g1$i2005000194153$lle005$o-$pE8.26$q-$rl$s-  $t0$u0$v0$w0$x0$y.i14976195$z03-06-09
996   $aComunitá, societá e politica nel Sud d'Italia$9233407
997   $aUNISALENTO
998   $ale005$b03-06-09$cm$da  $e-$fita$git $h0$i0

LEADER 01993nam  2200397   450 
001 9910688294103321
005 20230625131940.0
035   $a(CKB)5400000000046284
035   $a(NjHacI)995400000000046284
035   $a(EXLCZ)995400000000046284
100   $a20230625d2020      uy             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aNeuroprotection /$fedited by Matilde Otero-Losada, Capani, Francisco and Santiago Perez Lloret
210  1$aLondon, United Kingdom :$cIntechOpen,$d2020.
215   $a1 online resource (348 pages) $cillustrations
311   $a1-83969-261-8 
330   $aNeurological disease affects nearly 25%-30% of the world's population, exerting enormous financial strain on the healthcare system. Estimated current costs are around $800 annual billion, and this number is expected to increase exponentially as the global population ages. As such, new and alternative neuroprotective strategies are urgently needed. This book examines some of the most promising approaches in neuroprotection as well as discusses current goals and prospects. Organized into three sections, chapters cover such topics as the use of cannabinoids, medicinal plants, and essential oils in Alzheimer's and Parkinson's; protein misfolding and the neuroprotective potential of vitamin E in cerebral ischemia; and potential new neurological treatments and their mechanisms of action.
517   $aNeuroprotection 
606   $aNeuroprotective agents
606   $aNervous system$xDiseases$xTreatment
615  0$aNeuroprotective agents.
615  0$aNervous system$xDiseases$xTreatment.
676   $a616.8046
702   $aOtero-Losada$b Matilde
702   $aCapani$b Francisco
702   $aPerez-Lloret$b Santiago
801  0$bNjHacI
801  1$bNjHacl
906   $aBOOK
912   $a9910688294103321
996   $aNeuroprotection$91910085
997   $aUNINA